Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash Flow from Operating Activities
Net earnings (loss)	$ 22.4	$ (0.4)
Depreciation and amortization	22.5	22.1
Share-based compensation expense	4.9	4.9
Loss on sale of assets	0.2	0.7
Gain on sale of Infant and Pet Care business	(5.2)	0.0
Deferred compensation payments	(1.9)	(0.3)
Deferred income taxes	(16.7)	(0.1)
Other, net	5.4	5.4
Change in operating assets and liabilities	(78.5)	(78.7)
Net cash used by operating activities	(46.9)	(46.4)
Cash Flow from Investing Activities
Capital expenditures	(7.6)	(9.4)
Proceeds from sale of Infant and Pet Care business	95.8	0.0
Proceeds from sale of assets	0.0	4.0
Collection of deferred purchase price on accounts receivable sold	2.8	2.5
Payments for other investing activities	(1.3)	0.0
Net cash from (used by) from investing activities	89.7	(2.9)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	50.0	137.0
Cash payments on debt with original maturities greater than 90 days	(167.0)	(105.0)
Net decrease in debt with original maturities of 90 days or less	(0.1)	(0.9)
Net financing outflow from the Accounts Receivable Facility	(14.9)	(5.1)
Employee shares withheld for taxes	(1.5)	(1.5)
Payments for other financing activities	(2.4)	0.0
Net cash (used by) from financing activities	(135.9)	24.5
Effect of exchange rate changes on cash	3.3	(1.7)
Net decrease in cash and cash equivalents	(89.8)	(26.5)
Cash and cash equivalents, beginning of period	341.6	266.4
Cash and cash equivalents, end of period	$ 251.8	$ 239.9